| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |